---
title:  "Drug Screening: Combination Therapy for AML"
categories: 
  - DailyReport 
tag: 
  - AML
  - Drug Screening 
  - Dose Response 
---

There are rapidly growing [evidences](https://www.nature.com/articles/nrd.2017.55) that EZH2 inhibition has therapeutic potential for many cancers.  
<!-- more --> 
There is an ongoing effort at OSU to evaluate efficiency of targeting(inhibiting) EZH2 as a therapy for [AML](https://en.wikipedia.org/wiki/Acute_myeloid_leukemia).
EZH2 is an enzyme which through histone methylation (exactly trimethylation of H3K27me3)



